Brian V. Jones
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Brian V. Jones has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Ocean E. Clarke
University of Liverpool
2 shared publications - Vicky Bennett
Department of Life Sciences, University of Bath, Bath, BA2 7AY, UK
2 shared publications A. J. Slate
Department of Life Sciences, University of Bath, Bath, United Kingdom
1 shared publicationA. Preston
Department of Life Sciences, University of Bath, Bath, United Kingdom
1 shared publication- Anthony J. Slate
Department of Biology and Biochemistry, University of Bath, Claverton Down, Bath BA2 7AY, UK
1 shared publication - Ashley David Otter
UK Health Security Agency, London, UK
1 shared publication
Latest Publications
- 24 June 2025
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 220,p. e67966
An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
Catheter-associated urinary tract infections (CAUTIs) are among the most common healthcare-associated infections. Biofilm formation on urinary catheters is a key aspect in the pathogenesis of these infections, and frequently leads to blockage of catheters and serious complications such as pyelonephritis and septicaemia. Approaches to model and study biofilm formation in this setting are essential for both a fundamental understanding of the mechanisms underpinning the pathogenesis of CAUTI, as well as the development and robust pre-clinical evaluation of effective therapeutic strategies to control CAUTI and catheter blockage. This protocol describes an in vitro model of the catheterized urinary tract, which replicates the catheter closed drainage system as used in clinical practice, facilitating the study of CAUTI and catheter biofilm formation under representative conditions. Furthermore, this protocol details the application of the in vitro bladder model to evaluate the efficacy of antimicrobial catheter maintenance products, including products currently available on the NHS supply chain.
- 24 June 2025
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 220,p. e67966
An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
Catheter-associated urinary tract infections (CAUTIs) are among the most common healthcare-associated infections. Biofilm formation on urinary catheters is a key aspect in the pathogenesis of these infections, and frequently leads to blockage of catheters and serious complications such as pyelonephritis and septicaemia. Approaches to model and study biofilm formation in this setting are essential for both a fundamental understanding of the mechanisms underpinning the pathogenesis of CAUTI, as well as the development and robust pre-clinical evaluation of effective therapeutic strategies to control CAUTI and catheter blockage. This protocol describes an in vitro model of the catheterized urinary tract, which replicates the catheter closed drainage system as used in clinical practice, facilitating the study of CAUTI and catheter biofilm formation under representative conditions. Furthermore, this protocol details the application of the in vitro bladder model to evaluate the efficacy of antimicrobial catheter maintenance products, including products currently available on the NHS supply chain.
- 24 June 2025
- Published by MyJove Corporation
- No. 220,p. e67966
JoVE Video Dataset
Catheter-associated urinary tract infections (CAUTIs) are among the most common healthcare-associated infections. Biofilm formation on urinary catheters is a key aspect in the pathogenesis of these infections, and frequently leads to blockage of catheters and serious complications such as pyelonephritis and septicaemia. Approaches to model and study biofilm formation in this setting are essential for both a fundamental understanding of the mechanisms underpinning the pathogenesis of CAUTI, as well as the development and robust pre-clinical evaluation of effective therapeutic strategies to control CAUTI and catheter blockage. This protocol describes an in vitro model of the catheterized urinary tract, which replicates the catheter closed drainage system as used in clinical practice, facilitating the study of CAUTI and catheter biofilm formation under representative conditions. Furthermore, this protocol details the application of the in vitro bladder model to evaluate the efficacy of antimicrobial catheter maintenance products, including products currently available on the NHS supply chain.
- 24 June 2025
- Published by MyJove Corporation
- No. 220,p. e67966
JoVE Video Dataset
Catheter-associated urinary tract infections (CAUTIs) are among the most common healthcare-associated infections. Biofilm formation on urinary catheters is a key aspect in the pathogenesis of these infections, and frequently leads to blockage of catheters and serious complications such as pyelonephritis and septicaemia. Approaches to model and study biofilm formation in this setting are essential for both a fundamental understanding of the mechanisms underpinning the pathogenesis of CAUTI, as well as the development and robust pre-clinical evaluation of effective therapeutic strategies to control CAUTI and catheter blockage. This protocol describes an in vitro model of the catheterized urinary tract, which replicates the catheter closed drainage system as used in clinical practice, facilitating the study of CAUTI and catheter biofilm formation under representative conditions. Furthermore, this protocol details the application of the in vitro bladder model to evaluate the efficacy of antimicrobial catheter maintenance products, including products currently available on the NHS supply chain.
- Open Access
- 1 June 2023
- Published by Oxford University Press (OUP) in Journal of Applied Microbiology
- Vol. 134 (6)
Infection responsive coatings to reduce biofilm formation and encrustation of urinary catheters
The care of patients undergoing long-term urethral catheterization is frequently complicated by Proteus mirabilis infection. This organism forms dense, crystalline biofilms, which block catheters leading to serious clinical conditions. However, there are currently no truly effective approaches to control this problem. Here, we describe the development of a novel theranostic catheter coating, to simultaneously provide early warning of blockage, and actively delay crystalline biofilm formation. The coating comprises of a pH sensitive upper polymer layer (poly(methyl methacrylate-co-methacrylic acid); Eudragit S 100®) and a hydrogel base layer of poly(vinyl alcohol), which is loaded with therapeutic agents (acetohydroxamic acid or ciprofloxacin hydrochloride) and a fluorescent dye, 5(6)-carboxyfluorescein (CF). The elevation of urinary pH due to P. mirabilis urease activity results in the dissolution of the upper layer and release of cargo agents contained in the base layer. Experiments using in vitro models, which were representative of P. mirabilis catheter-associated urinary tract infections, demonstrated that these coatings significantly delay time taken for catheters to block. Coatings containing both CF dye and ciprofloxacin HCl were able to provide an average of ca. 79 h advanced warning of blockage and extend catheter lifespan ca. 3.40-fold. This study has demonstrated the potential for theranostic, infection-responsive coatings to form a promising approach to combat catheter encrustation and actively delay blockage.
- 1 June 2023
- Published by Oxford University Press (OUP) in Journal of Applied Microbiology
- Vol. 134 (6)
Open AccessInfection responsive coatings to reduce biofilm formation and encrustation of urinary catheters
The care of patients undergoing long-term urethral catheterization is frequently complicated by Proteus mirabilis infection. This organism forms dense, crystalline biofilms, which block catheters leading to serious clinical conditions. However, there are currently no truly effective approaches to control this problem. Here, we describe the development of a novel theranostic catheter coating, to simultaneously provide early warning of blockage, and actively delay crystalline biofilm formation. The coating comprises of a pH sensitive upper polymer layer (poly(methyl methacrylate-co-methacrylic acid); Eudragit S 100®) and a hydrogel base layer of poly(vinyl alcohol), which is loaded with therapeutic agents (acetohydroxamic acid or ciprofloxacin hydrochloride) and a fluorescent dye, 5(6)-carboxyfluorescein (CF). The elevation of urinary pH due to P. mirabilis urease activity results in the dissolution of the upper layer and release of cargo agents contained in the base layer. Experiments using in vitro models, which were representative of P. mirabilis catheter-associated urinary tract infections, demonstrated that these coatings significantly delay time taken for catheters to block. Coatings containing both CF dye and ciprofloxacin HCl were able to provide an average of ca. 79 h advanced warning of blockage and extend catheter lifespan ca. 3.40-fold. This study has demonstrated the potential for theranostic, infection-responsive coatings to form a promising approach to combat catheter encrustation and actively delay blockage.
- Open Access
- 5 April 2023
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 14
Lipopolysaccharide structure modulates cationic biocide susceptibility and crystalline biofilm formation in Proteus mirabilis
Chlorhexidine (CHD) is a cationic biocide used ubiquitously in healthcare settings. Proteus mirabilis, an important pathogen of the catheterized urinary tract, and isolates of this species are often described as “resistant” to CHD-containing products used for catheter infection control. To identify the mechanisms underlying reduced CHD susceptibility in P. mirabilis, we subjected the CHD tolerant clinical isolate RS47 to random transposon mutagenesis and screened for mutants with reduced CHD minimum inhibitory concentrations (MICs). One mutant recovered from these screens (designated RS47-2) exhibited ~ 8-fold reduction in CHD MIC. Complete genome sequencing of RS47-2 showed a single mini-Tn5 insert in the waaC gene involved in lipopolysaccharide (LPS) inner core biosynthesis. Phenotypic screening of RS47-2 revealed a significant increase in cell surface hydrophobicity and serum susceptibility compared to the wildtype, and confirmed defects in LPS production congruent with waaC inactivation. Disruption of waaC was also associated with increased susceptibility to a range of other cationic biocides but did not affect susceptibility to antibiotics tested. Complementation studies showed that repression of smvA efflux activity in RS47-2 further increased susceptibility to CHD and other cationic biocides, reducing CHD MICs to values comparable with the most CHD susceptible isolates characterized. The formation of crystalline biofilms and blockage of urethral catheters was also significantly attenuated in RS47-2. Taken together, these data show that aspects of LPS structure and upregulation of the smvA efflux system function in synergy to modulate susceptibility to CHD and other cationic biocides, and that LPS structure is also an important factor in P. mirabilis crystalline biofilm formation.
- 5 April 2023
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 14
Open AccessLipopolysaccharide structure modulates cationic biocide susceptibility and crystalline biofilm formation in Proteus mirabilis
Chlorhexidine (CHD) is a cationic biocide used ubiquitously in healthcare settings. Proteus mirabilis, an important pathogen of the catheterized urinary tract, and isolates of this species are often described as “resistant” to CHD-containing products used for catheter infection control. To identify the mechanisms underlying reduced CHD susceptibility in P. mirabilis, we subjected the CHD tolerant clinical isolate RS47 to random transposon mutagenesis and screened for mutants with reduced CHD minimum inhibitory concentrations (MICs). One mutant recovered from these screens (designated RS47-2) exhibited ~ 8-fold reduction in CHD MIC. Complete genome sequencing of RS47-2 showed a single mini-Tn5 insert in the waaC gene involved in lipopolysaccharide (LPS) inner core biosynthesis. Phenotypic screening of RS47-2 revealed a significant increase in cell surface hydrophobicity and serum susceptibility compared to the wildtype, and confirmed defects in LPS production congruent with waaC inactivation. Disruption of waaC was also associated with increased susceptibility to a range of other cationic biocides but did not affect susceptibility to antibiotics tested. Complementation studies showed that repression of smvA efflux activity in RS47-2 further increased susceptibility to CHD and other cationic biocides, reducing CHD MICs to values comparable with the most CHD susceptible isolates characterized. The formation of crystalline biofilms and blockage of urethral catheters was also significantly attenuated in RS47-2. Taken together, these data show that aspects of LPS structure and upregulation of the smvA efflux system function in synergy to modulate susceptibility to CHD and other cationic biocides, and that LPS structure is also an important factor in P. mirabilis crystalline biofilm formation.
- Open Access
A Novel Inducible Prophage from Burkholderia vietnamiensis G4 Is Widely Distributed across the Species and Has Lytic Activity against Pathogenic Burkholderia
Burkholderia species have environmental, industrial and medical significance, and are important opportunistic pathogens in individuals with cystic fibrosis (CF). Using a combination of existing and newly determined genome sequences, this study investigated prophage carriage across the species B. vietnamiensis, and also isolated spontaneously inducible prophages from a reference strain, G4. Eighty-one B. vietnamiensis genomes were bioinformatically screened for prophages using PHASTER (Phage Search Tool Enhanced Release) and prophage regions were found to comprise up to 3.4% of total genetic material. Overall, 115 intact prophages were identified and there was evidence of polylysogeny in 32 strains. A novel, inducible Mu-like phage (vB_BvM-G4P1) was isolated from B. vietnamiensis G4 that had lytic activity against strains of five Burkholderia species prevalent in CF infections, including the Boston epidemic B. dolosa strain SLC6. The cognate prophage to vB_BvM-G4P1 was identified in the lysogen genome and was almost identical (>93.5% tblastx identity) to prophages found in 13 other B. vietnamiensis strains (17% of the strain collection). Phylogenomic analysis determined that the G4P1-like prophages were widely distributed across the population structure of B. vietnamiensis. This study highlights how genomic characterization of Burkholderia prophages can lead to the discovery of novel bacteriophages with potential therapeutic or biotechnological applications.
Open AccessA Novel Inducible Prophage from Burkholderia vietnamiensis G4 Is Widely Distributed across the Species and Has Lytic Activity against Pathogenic Burkholderia
Burkholderia species have environmental, industrial and medical significance, and are important opportunistic pathogens in individuals with cystic fibrosis (CF). Using a combination of existing and newly determined genome sequences, this study investigated prophage carriage across the species B. vietnamiensis, and also isolated spontaneously inducible prophages from a reference strain, G4. Eighty-one B. vietnamiensis genomes were bioinformatically screened for prophages using PHASTER (Phage Search Tool Enhanced Release) and prophage regions were found to comprise up to 3.4% of total genetic material. Overall, 115 intact prophages were identified and there was evidence of polylysogeny in 32 strains. A novel, inducible Mu-like phage (vB_BvM-G4P1) was isolated from B. vietnamiensis G4 that had lytic activity against strains of five Burkholderia species prevalent in CF infections, including the Boston epidemic B. dolosa strain SLC6. The cognate prophage to vB_BvM-G4P1 was identified in the lysogen genome and was almost identical (>93.5% tblastx identity) to prophages found in 13 other B. vietnamiensis strains (17% of the strain collection). Phylogenomic analysis determined that the G4P1-like prophages were widely distributed across the population structure of B. vietnamiensis. This study highlights how genomic characterization of Burkholderia prophages can lead to the discovery of novel bacteriophages with potential therapeutic or biotechnological applications.